MUREX BIOTECH LIMITED
Get an alert when MUREX BIOTECH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-30 (in 6mo)
Last made up 2025-11-16
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£46M
+3.8% vs 2023
Employees
0
Average over period
Profit before tax
£2M
+14.8% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | — | — | |
| Profit before tax | £2,012,000 | £2,310,000 | |
| Net profit | £1,526,000 | £1,717,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £44,762,000 | £46,479,000 | |
| Net assets | £44,762,000 | £46,479,000 | |
| Equity | £44,762,000 | £46,479,000 | |
| Average employees | 0 | 0 | |
| Wages | £23,000 | — | |
| Directors' remuneration | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
+3.8%
£44,762,000 £46,479,000
-
Employees
—
Not reported
-
Profit before tax
+14.8%
£2,012,000 £2,310,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Gearing (liabilities / total assets) | 1.0% | 2.2% | |
| Current ratio | 103.90x | 45.95x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- MUREX BIOTECH LIMITED 1996-02-01 → present
- MUREX DIAGNOSTICS BRANCHES LIMITED 1992-05-05 → 1996-02-01
- BCW BRANCHES LIMITED 1992-01-13 → 1992-05-05
- ALNERY NO. 1150 LIMITED 1991-12-12 → 1992-01-13
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Ernst & Young, Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company generated a net profit of £1,717,000 (2023: net profit £1,526,000), has net assets of £46,479,000 (2023: net assets £44,762,000) and current assets of the Company exceed its current liabilities by £46,479,000 (2023: net assets £44,762,000). Interest income is expected to continue in the foreseeable future. Therefore, after making enquiries, the Directors have a reasonable expectation that the Company will continue in operational existence for a period of twelve months from the date of approval of these financial statements.”
Significant events
- “There were no significant events between the Balance Sheet date and the date of signing of the financial statements, affecting the Company, which require disclosure.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 54 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GOGAY, Kevan | Secretary | 2016-09-28 | — | — |
| CAMPBELL, Ross Iain | Director | 2025-04-25 | Apr 1976 | British |
| CLAYTON, Michael Robert Kendall | Director | 2020-03-23 | Apr 1974 | British |
| WENNER, James Russell | Director | 2025-12-10 | Sep 1967 | American |
Show 54 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROWN, Stephen | Secretary | 2007-04-02 | 2007-10-25 |
| DAVIES, Alison Elizabeth | Secretary | 2000-11-01 | 2006-09-30 |
| NORRINGTON, Simon Guy | Secretary | 2007-10-25 | 2016-06-27 |
| NORRINGTON, Simon Guy | Secretary | 2006-09-30 | 2007-04-02 |
| OSBORNE, Charles Fremont | Secretary | 1996-08-06 | 1999-02-20 |
| RAMSEY, Steven Charles | Secretary | 1993-05-10 | 1996-08-06 |
| ROBERTS, Helen Janet | Secretary | 1999-02-22 | 2000-11-01 |
| STRAYER, Richard Dean | Secretary | 1992-01-13 | 1992-04-02 |
| WATSON, Michael Alan | Secretary | 1992-04-23 | 1993-05-10 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Secretary | 1991-12-12 | 1992-01-13 |
| BRACKEN, Sharon Jeanne | Director | 2007-10-25 | 2008-04-25 |
| BRACKEN, Sharon Jeanne | Director | 2007-01-19 | 2007-04-02 |
| BRANIGHAN, Kenneth Robert | Director | 2001-01-16 | 2002-12-20 |
| BROWN, Stephen | Director | 2005-11-30 | 2006-02-02 |
| BRUSHETT, Samuel Augustine | Director | 1992-01-13 | 1993-04-13 |
| CORCORAN, Ciaran | Director | 2011-09-29 | 2015-05-31 |
| CORKER, Charles Stanley | Director | 1992-04-23 | 1993-01-29 |
| COUGHLAN, Gary Patrick | Director | 1998-11-30 | 2001-03-31 |
| CUSICK, Charles Robert | Director | 1992-01-13 | 1999-10-01 |
| DAVIES, Alison Elizabeth | Director | 2023-10-15 | 2025-12-10 |
| FORREST, Andrew David Hall | Director | 2005-01-26 | 2007-10-25 |
| FREYMAN, Thomas Craig | Director | 2001-03-31 | 2016-01-29 |
| GUIDETTI, Guido | Director | 1993-11-01 | 1999-06-17 |
| HALL, Gary James | Director | 2015-11-10 | 2018-09-27 |
| HARRIS, Neil | Director | 2018-08-31 | 2025-04-25 |
| HAYWOOD, Mark | Director | 1998-11-30 | 2004-07-30 |
| HUDSON, Susan Michelle | Director | 2016-04-22 | 2018-08-31 |
| HUNT, Frank Richard | Director | 1992-01-13 | 1992-04-23 |
| IGLESIAS FERNANDEZ, Luis | Director | 2002-12-20 | 2005-11-30 |
| KRAMMER, Karen Ann | Director | 2020-03-01 | 2022-09-19 |
| MARK, David | Director | 2004-07-22 | 2004-12-13 |
| MCCOY JR, John Arthur | Director | 2022-09-19 | 2023-10-15 |
| MOLITOR, Stefan Norbet | Director | 2008-04-25 | 2011-09-29 |
| MORGAN, Peter John, Dr | Director | 2015-05-13 | 2016-09-26 |
| MOUNTRICHAS, Georgios | Director | 2018-09-27 | 2020-03-23 |
| OSBORNE, Charles Fremont | Director | 1996-08-06 | 1999-07-30 |
| PARSONS, William Thomas | Director | 1995-11-01 | 1997-11-28 |
| PARTYKA, Kenneth Mark | Director | 2005-10-21 | 2007-01-19 |
| RAMSEY, Steven Charles | Director | 1995-11-01 | 1999-10-28 |
| RANKIN, John Harry | Director | 2007-04-02 | 2008-09-26 |
| REARDON, Thomas | Director | 2010-08-24 | 2011-09-29 |
| SCHUELER, John Otto | Director | 1998-11-30 | 2001-01-16 |
| SIKORSKI, Jurek Stefan | Director | 1992-04-23 | 1993-08-03 |
| SILVESTON, Ronald Peter | Director | 1992-04-23 | 2005-12-31 |
| SMITH, Michael James | Director | 2008-09-26 | 2015-10-31 |
| STEWART, Jeffrey Ryan | Director | 2007-10-25 | 2009-05-02 |
| STRAYER, Richard Dean | Director | 1992-01-13 | 1992-04-02 |
| SYMONS, Philip David Frederick | Director | 1992-01-23 | 2005-10-21 |
| THOLEN, John David | Director | 1995-11-01 | 1997-01-20 |
| WARREN, Frederic Michael Patrick | Director | 1992-01-13 | 1999-10-11 |
| WATSON, Michael Alan | Director | 1992-04-23 | 1993-05-10 |
| YOOR, Brian | Director | 2016-01-29 | 2020-02-29 |
| ALNERY INCORPORATIONS NO 1 LIMITED | Corporate Nominee Director | 1991-12-12 | 1992-01-13 |
| ALNERY INCORPORATIONS NO 2 LIMITED | Corporate Nominee Director | 1991-12-12 | 1992-01-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Abbott Laboratories Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 210 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-15 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-05 | AA | accounts | Accounts with accounts type full | |
| 2025-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-22 | AA | accounts | Accounts with accounts type full | |
| 2023-11-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-25 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-25 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-24 | AA | accounts | Accounts with accounts type full | |
| 2022-11-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-27 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-27 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-25 | AA | accounts | Accounts with accounts type full | |
| 2021-11-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-07 | AA | accounts | Accounts with accounts type full | |
| 2021-09-17 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2020-11-18 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.